New Key Statistics Module, Z-Score and F-Score
OTCPK:TAIPY Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | -1,648.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,260.00 |
| EPS (TTM) $ | 4,757,535.48 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.76 |
| EV-to-EBITDA | -13.76 |
| PEG | -- |
| Shares Outstanding M | -- |
| Net Margin (%) | 2.54 |
| Operating Margin % | 5.80 |
| Pre-tax Margin (%) | 5.23 |
| Quick Ratio | 4.37 |
| Current Ratio | 5.16 |
| ROA % (ttm) | 0.83 |
| ROE % (ttm) | 1.00 |
| ROIC % (ttm) | 1.75 |
| Dividend Yield % | 0.61 |
| Altman Z-Score | 4.59 |
TAIPY Number of Guru Trades
TAIPY Volume of Guru Trades
Gurus Latest Trades with OTCPK:TAIPY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TAIPY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Taisho Pharmaceutical Holdings Co Ltd Insider Transactions
No Available Data
News about OTCPK:TAIPY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers